References
- Acosta N, Whelan FJ, Somayaji R, Poonja A, Surette MG, Rabin HR, Parkins MD. The evolving cystic fibrosis microbiome: a comparative cohort study spanning 16 years. Ann Am Thorac Soc. 2017 Aug;14(8):1288–1297. https://doi.org/10.1513/AnnalsATS.201609-668OC
- Allais L, Kerckhof FM, Verschuere S, Bracke KR, De Smet R, Laukens D, Van den Abbeele P, De Vos M, Boon N, Brusselle GG, et al. Chronic cigarette smoke exposure induces microbial and inflammatory shifts and mucin changes in the murine gut. Environ Microbiol. 2016 May;18(5):1352–1363. https://doi.org/10.1111/1462-2920.12934
- Barcik W, Boutin RCT, Sokolowska M, Finlay BB. The role of lung and gut microbiota in the pathology of asthma. Immunity. 2020 Feb 18;52(2):241–255. https://doi.org/10.1016/j.immuni.2020.01.007
- Belkaid Y, Hand TW. Role of the microbiota in immunity and inflammation. Cell. 2014 Mar;157(1):121–141. https://doi.org/10.1016/j.cell.2014.03.011
- Belkaid Y, Harrison OJ. Homeostatic immunity and the microbiota. Immunity. 2017 Apr;46(4):562–576. https://doi.org/10.1016/j.immuni.2017.04.008
- Berg G, Rybakova D, Fischer D, Cernava T, Vergès MCC, Charles T, Chen X, Cocolin L, Eversole K, Corral GH, et al. Microbiome definition re-visited: old concepts and new challenges. Microbiome. 2020 Dec;8(1):103. https://doi.org/10.1186/s40168-020-00875-0
- Burgel P-R, Contoli M, López-Campos JL. Acute exacerbations of the pulmonary diseases. Sheffield (UK): European Respiratory Society; 2017. https://doi.org/10.1183/2312508X.erm7717
- Cait A, Hughes MR, Antignano F, Cait J, Dimitriu PA, Maas KR, Reynolds LA, Hacker L, Mohr J, Finlay BB, et al. Microbiome-driven allergic lung inflammation is ameliorated by short-chain fatty acids. Mucosal Immunol. 2018 May;11(3):785–795. https://doi.org/10.1038/mi.2017.75
- Carmody LA, Zhao J, Schloss PD, Petrosino JF, Murray S, Young VB, Li JZ, LiPuma JJ. Changes in cystic fibrosis airway microbiota at pulmonary exacerbation. Ann Am Thorac Soc. 2013 Jun; 10(3):179–187. https://doi.org/10.1513/AnnalsATS.201211-107OC
- Castro-Nallar E, Shen Y, Freishtat RJ, Pérez-Losada M, Manimaran S, Liu G, Johnson WE, Crandall KA. Integrating microbial and host transcriptomics to characterize asthma-associated microbial communities. BMC Med Genomics. 2015 Dec;8(1):50. https://doi.org/10.1186/s12920-015-0121-1
- Chung KF. Airway microbial dysbiosis in asthmatic patients: A target for prevention and treatment? J Allergy Clin Immunol. 2017 Apr; 139(4):1071–1081. https://doi.org/10.1016/j.jaci.2017.02.004
- Cox MJ, Allgaier M, Taylor B, Baek MS, Huang YJ, Daly RA, Karaoz U, Andersen GL, Brown R, Fujimura KE, et al. Airway microbiota and pathogen abundance in age-stratified cystic fibrosis patients. PLoS One. 2010 Jun 23;5(6):e11044. https://doi.org/10.1371/journal.pone.0011044
- Cribbs SK, Beck JM. Microbiome in the pathogenesis of cystic fibrosis and lung transplant-related disease. Transl Res. 2017 Jan; 179:84–96. https://doi.org/10.1016/j.trsl.2016.07.022
- Cuthbertson L, Walker AW, Oliver AE, Rogers GB, Rivett DW, Hampton TH, Ashare A, Elborn JS, De Soyza A, Carroll MP, et al. Lung function and microbiota diversity in cystic fibrosis. Microbiome. 2020 Dec;8(1):45. https://doi.org/10.1186/s40168-020-00810-3
- Denner DR, Sangwan N, Becker JB, Hogarth DK, Oldham J, Castillo J, Sperling AI, Solway J, Naureckas ET, Gilbert JA, et al. Corticosteroid therapy and airflow obstruction influence the bronchial microbiome, which is distinct from that of bronchoalveolar lavage in asthmatic airways. J Allergy Clin Immunol. 2016 May; 137(5):1398–1405.e3. https://doi.org/10.1016/j.jaci.2015.10.017
- Dickson RP, Erb-Downward JR, Huffnagle GB. The role of the bacterial microbiome in lung disease. Expert Rev Respir Med. 2013 Jun;7(3):245–257. https://doi.org/10.1586/ers.13.24
- Dickson RP, Martinez FJ, Huffnagle GB. The role of the microbiome in exacerbations of chronic lung diseases. Lancet. 2014 Aug; 384(9944): 691–702. https://doi.org/10.1016/S0140-6736(14)61136-3
- Dima E, Kyriakoudi A, Kaponi M, Vasileiadis I, Stamou P, Koutsoukou A, Koulouris NG, Rovina N. The lung microbiome dynamics between stability and exacerbation in chronic obstructive pulmonary disease (COPD): Current perspectives. Respir Med. 2019 Oct;157:1–6. https://doi.org/10.1016/j.rmed.2019.08.012
- Ditz B, Christenson S, Rossen J, Brightling C, Kerstjens HAM, van den Berge M, Faiz A. Sputum microbiome profiling in COPD: beyond singular pathogen detection. Thorax. 2020 Apr;75(4):338–344. https://doi.org/10.1136/thoraxjnl-2019-214168
- Durack J, Lynch SV, Nariya S, Bhakta NR, Beigelman A, Castro M, Dyer AM, Israel E, Kraft M, Martin RJ, et al.; National Heart, Lung and Blood Institute’s “AsthmaNet”. Features of the bronchial bacterial microbiome associated with atopy, asthma, and responsiveness to inhaled corticosteroid treatment. J Allergy Clin Immunol. 2017 Jul;140(1):63–75. https://doi.org/10.1016/j.jaci.2016.08.055
- Einarsson GG, Comer DM, McIlreavey L, Parkhill J, Ennis M, Tunney MM, Elborn JS. Community dynamics and the lower airway microbiota in stable chronic obstructive pulmonary disease, smokers and healthy non-smokers. Thorax. 2016 Sep;71(9):795–803. https://doi.org/10.1136/thoraxjnl-2015-207235
- Françoise A, Héry-Arnaud G. The microbiome in cystic fibrosis pulmonary disease. Genes (Basel). 2020 May 11;11(5):536. https://doi.org/10.3390/genes11050536
- Gillanders LJ, Elborn JS, Gilpin DF, Schneiders T, Tunney MM. The airway microbiome in cystic fibrosis: challenges for therapy. Therapy. 2011 Nov;8(6):645–660. https://doi.org/10.2217/thy.11.81
- Goto T. Airway microbiota as a modulator of lung cancer. Int J Mol Sci. 2020 Apr 26;21(9):3044. https://doi.org/10.3390/ijms21093044
- Haldar K, George L, Wang Z, Mistry V, Ramsheh MY, Free RC, John C, Reeve NF, Miller BE, Tal-Singer R, et al. The sputum microbiome is distinct between COPD and health, independent of smoking history. Respir Res. 2020 Dec;21(1):183. https://doi.org/10.1186/s12931-020-01448-3
- Hoffman L, Surette M. What to expect when you’re expectorating: cystic fibrosis exacerbations and microbiota. Ann Am Thorac Soc. 2013 Jun;10(3):249–250. https://doi.org/10.1513/AnnalsATS.201304-086ED
- Huang YJ, Erb-Downward JR, Dickson RP, Curtis JL, Huffnagle GB, Han MK. Understanding the role of the microbiome in chronic obstructive pulmonary disease: principles, challenges, and future directions. Transl Res. 2017 Jan;179:71–83. https://doi.org/10.1016/j.trsl.2016.06.007
- Huang YJ, Nariya S, Harris JM, Lynch SV, Choy DF, Arron JR, Boushey H. The airway microbiome in patients with severe asthma: associations with disease features and severity. J Allergy Clin Immunol. 2015 Oct;136(4):874–884. https://doi.org/10.1016/j.jaci.2015.05.044
- Huffnagle GB, Dickson RP, Lukacs NW. The respiratory tract microbiome and lung inflammation: a two-way street. Mucosal Immunol. 2017 Mar;10(2):299–306. https://doi.org/10.1038/mi.2016.108
- Kovaleva OV, Romashin D, Zborovskaya IB, Davydov MM, Shogenov MS, Gratchev A. Human lung microbiome on the way to cancer. J Immunol Res. 2019 Jul 29;2019:1394191. https://doi.org/10.1155/2019/1394191
- Kozik AJ, Huang YJ. The microbiome in asthma: Role in pathogenesis, phenotype, and response to treatment. Ann Allergy Asthma Immunol. 2019 Mar;122(3):270–275. https://doi.org/10.1016/j.anai.2018.12.005
- LiPuma JJ. The changing microbial epidemiology in cystic fibrosis. Clin Microbiol Rev. 2010 Apr;23(2):299–323. https://doi.org/10.1128/CMR.00068-09
- Lloyd CM, Marsland BJ. Lung homeostasis: influence of age, microbes and the immune system. Immunity. 2017 Apr;46(4):549–561. https://doi.org/10.1016/j.immuni.2017.04.005
- Loverdos K, Bellos G, Kokolatou L, Vasileiadis I, Giamarellos E, Pecchiari M, Koulouris N, Koutsoukou A, Rovina N. Lung microbiome in asthma: Current perspective. J Clin Med. 2019 Nov 14; 8(11):1967. https://doi.org/10.3390/jcm8111967
- Malinowska M, Tokarz-Deptuła B, Deptuła W. [Mikrobiom człowieka] (in Polish). Postepy Mikrobiol. 2017;56(1):33–42.
- Martinez FJ, Erb-Downward JR, Huffnagle GB. Significance of the microbiome in chronic obstructive pulmonary disease. Ann Am Thorac Soc. 2013 Dec;10 Supplement:S170–S179. https://doi.org/10.1513/AnnalsATS.201306-204AW
- Moffatt MF, Cookson WO. The lung microbiome in health and disease. Clin Med (Lond). 2017 Dec;17(6):525–529. https://doi.org/10.7861/clinmedicine.17-6-525
- Noval Rivas M, Crother TR, Arditi M. The microbiome in asthma. Curr Opin Pediatr. 2016 Dec;28(6):764–771. https://doi.org/10.1097/MOP.0000000000000419
- O’Dwyer DN, Dickson RP, Moore BB. The lung microbiome, immunity and the pathogenesis of chronic lung disease. J Immunol. 2016 Jun 15;196(12):4839–4847. https://doi.org/10.4049/jimmunol.1600279
- Ogunrinola GA, Oyewale JO, Oshamika OO, Olasehinde GI. The human microbiome and its impacts on health. Int J Microbiol. 2020 Jun 12;2020:1–7. https://doi.org/10.1155/2020/8045646
- Papadopoulos NG, Christodoulou I, Rohde G, Agache I, Almqvist C, Bruno A, Bonini S, Bont L, Bossios A, Bousquet J, et al. Viruses and bacteria in acute asthma exacerbations – A GA2LEN--DARE* systematic review. Allergy. 2011 Apr;66(4): 458–468. https://doi.org/10.1111/j.1398-9995.2010.02505.x
- Paudel KR, Dharwal V, Patel VK, Galvao I, Wadhwa R, Malyla V, Shen SS, Budden KF, Hansbro NG, Vaughan A, et al. Role of lung microbiome in innate immune response associated with chronic lung diseases. Frontiers in Medicine. 2020 Sep 18;7:554. https://doi.org/10.3389/fmed.2020.00554
- Pulvirenti G, Parisi GF, Giallongo A, Papale M, Manti S, Savasta S, Licari A, Marseglia GL, Leonardi S. Lower airway microbiota. Front Pediatr. 2019 Sep 27;7:393. https://doi.org/10.3389/fped.2019.00393
- Ramírez-Labrada AG, Isla D, Artal A, Arias M, Rezusta A, Pardo J, Gálvez EM. The influence of lung microbiota on lung carcinogenesis, immunity and immunotherapy. Trends Cancer. 2020 Feb;6(2):86–97. https://doi.org/10.1016/j.trecan.2019.12.007
- Rogers GB, Bruce KD, Hoffman LR. How can the cystic fibrosis respiratory microbiome influence our clinical decision-making? Curr Opin Pulm Med. 2017 Nov;23(6):536–543. https://doi.org/10.1097/MCP.0000000000000419
- Samuelson DR, Welsh DA, Shellito JE. Regulation of lung immunity and host defense by the intestinal microbiota. Front Microbiol. 2015 Oct 7;6:1085. https://doi.org/10.3389/fmicb.2015.01085
- Simpson JL, Daly J, Baines KJ, Yang IA, Upham JW, Reynolds PN, Hodge S, James AL, Hugenholtz P, Willner D, et al. Airway dysbiosis: Haemophilus influenzae and Tropheryma in poorly controlled asthma. Eur Respir J. 2016 Mar;47(3):792–800. https://doi.org/10.1183/13993003.00405-2015
- Sommariva M, Le Noci V, Bianchi F, Camelliti S, Balsari A, Tagliabue E, Sfondrini L. The lung microbiota: role in maintaining pulmonary immune homeostasis and its implications in cancer development and therapy. Cell Mol Life Sci. 2020 Jul;77(14):2739–2749. https://doi.org/10.1007/s00018-020-03452-8
- Surette MG. The cystic fibrosis lung microbiome. Ann Am Thorac Soc. 2014 Jan;11 Suppl 1:S61–S65. https://doi.org/10.1513/AnnalsATS.201306-159MG
- Sverrild A, Kiilerich P, Brejnrod A, Pedersen R, Porsbjerg C, Bergqvist A, Erjefält JS, Kristiansen K, Backer V. Eosinophilic airway inflammation in asthmatic patients is associated with an altered airway microbiome. J Allergy Clin Immunol. 2017 Aug;140(2): 407–417.e11. https://doi.org/10.1016/j.jaci.2016.10.046
- Taylor SL, Leong LEX, Choo JM, Wesselingh S, Yang IA, Upham JW, Reynolds PN, Hodge S, James AL, Jenkins C, et al. Inflammatory phenotypes in patients with severe asthma are associated with distinct airway microbiology. J Allergy Clin Immunol. 2018 Jan;141(1):94–103.e15. https://doi.org/10.1016/j.jaci.2017.03.044
- Toraldo DM, Conte L. Influence of the lung microbiota dysbiosis in chronic obstructive pulmonary disease exacerbations: the controversial use of corticosteroid and antibiotic treatments and the role of eosinophils as a disease marker. J Clin Med Res. 2019;11(10):667–675. https://doi.org/10.14740/jocmr3875
- Wang J, Li F, Tian Z. Role of microbiota on lung homeostasis and diseases. Sci China Life Sci. 2017 Dec;60(12):1407–1415. https://doi.org/10.1007/s11427-017-9151-1
- Wang Z, Bafadhel M, Haldar K, Spivak A, Mayhew D, Miller BE, Tal-Singer R, Johnston SL, Ramsheh MY, Barer MR, et al. Lung microbiome dynamics in COPD exacerbations. Eur Respir J. 2016 Apr;47(4):1082–1092. https://doi.org/10.1183/13993003.01406-2015
- Xu N, Wang L, Li C, Ding C, Li C, Fan W, Cheng C, Gu B. Microbiota dysbiosis in lung cancer: evidence of association and potential mechanisms. Transl Lung Cancer Res. 2020 Aug;9(4):1554–1568. https://doi.org/10.21037/tlcr-20-156
- Yang X, Feng H, Zhan X, Zhang C, Cui R, Zhong L, Ying S, Chen Z. Early-life vancomycin treatment promotes airway inflammation and impairs microbiome homeostasis. Aging (Albany NY). 2019 Apr 13; 11(7):2071–2081. https://doi.org/10.18632/aging.101901